Share

    


Home / Search Results

Search Results

You searched for:

Independent oncology is critical to our healthcare system. Help independent oncology stay off the “endangered species” list by supporting adoption of new digital technologies.
From January 24 to 28, 2022, ACCC co-sponsored Health Care Value Week—a series of virtual events supporting the advancement of value-based care.
At the ACCC 45th Annual Meeting and Cancer Center Business Summit, I announced my 2019-2020 President’s Theme: Collaborate. Educate. Compensate: A Prescription for Sustainable Care Delivery.
Secretary Alex Azar has expressed strong interest in revitalizing Medicare’s Competitive Acquisition Program (CAP) and introducing negotiation into Part B drug pricing.
As the team of Northwest Medical Specialties discussed its approach to meeting OCM requirements, we realized that the program required rigor and processes like those found in clinical research programs, and an idea surfaced. Employing practices, procedures, and rules commonly used by those who work in a clinical research setting looked like a promising avenue for OCM implementation.
2017 ACCC Innovator Award winner Mitchell Cancer Institute developed a universal oncology nurse navigation acuity tool that measures 11 factors directly impacting the need for and level of navigation services, including staging and diagnosis, co-morbidities, hospitalizations, and family support.
Organizing care around a patient’s diagnosis with multidisciplinary, disease-specific teams is value-based healthcare delivery.
What is the correct number of physicians and support staff needed to meet the requirements of the cancer program? There may not be a single answer to this complex question.
This article presents a framework for collaboration between small community oncology programs—often located in rural settings—and large cancer centers—often located in urban settings.
This article examines the hallmark of successful oncology programs—an action-oriented strategic planning process, specific to the unique nature of cancer care—and assesses the “must haves” for cancer program planning, offering a roadmap to follow for effective oncology strategy.
Shifting our healthcare system from payment based on “volume” to one based on “value” has become a familiar and frequent adage among policymakers in recent year
In 2016, we saw the Obama Administration finalize regulations around sweeping physician payment reform in Medicare, oncology practices nationwide navigate the first year of the Oncology Care Model (OCM), policymakers try—and fail—to push through drug pricing reform with a national mandatory demonstration program, the 21st Century Cures Act signed into law, and the drug pricing debate hit a fever …
The CY 2017 conversion factor is estimated to be $35.8887, which is slightly higher than the 2016 conversion factor of $35.8043.
A number of excellent strategic planning tools have been published by consultancies and academia, but we have found that they often lack the necessary specificity for oncology and, more importantly, do not fully address the all-important question for healthcare organizations—how do we plan for an uncertain, value-based future?
It is incredibly important for managers and administrators to be able to report the true impact navigation programs have on cancer patients, as well as the cancer program.